| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation date | 2010-04-08 22:12:51 UTC |
|---|
| Update date | 2019-11-26 03:14:13 UTC |
|---|
| Primary ID | FDB017114 |
|---|
| Secondary Accession Numbers | Not Available |
|---|
| Chemical Information |
|---|
| FooDB Name | Epicatechin 3-gallate |
|---|
| Description | (-)-Epicatechin 3-O-gallate, also known as 3-O-galloylepicatechin or ECG, belongs to the class of organic compounds known as catechin gallates. These are organic compounds containing a gallate moiety glycosidically linked to a catechin (-)-Epicatechin 3-O-gallate is a bitter tasting compound (-)-Epicatechin 3-O-gallate is found, on average, in the highest concentration within a few different foods, such as red tea, herbal tea, and green tea and in a lower concentration in peppermints (Mentha X piperita), common grapes (Vitis vinifera), and medlars (Mespilus germanica) (-)-Epicatechin 3-O-gallate has also been detected, but not quantified in, several different foods, such as kiwis (Actinidia chinensis), rubus (blackberry, raspberry), sweet oranges (Citrus sinensis), common wheats (Triticum aestivum), and pistachios (Pistacia vera). This could make (-)-epicatechin 3-O-gallate a potential biomarker for the consumption of these foods. Based on a literature review a small amount of articles have been published on (-)-Epicatechin 3-O-gallate. |
|---|
| CAS Number | 1257-08-5 |
|---|
| Structure | |
|---|
| Synonyms | | Synonym | Source |
|---|
| (-)-cis-3,3',4',5,7-Pentahydroxyflavane 3-gallate | ChEBI | | 3-Gallate(-)-epicatechol | ChEBI | | 3-O-Galloylepicatechin | ChEBI | | ECG | ChEBI | | Teatannin | ChEBI | | (-)-cis-3,3',4',5,7-Pentahydroxyflavane 3-gallic acid | Generator | | 3-Gallic acid(-)-epicatechol | Generator | | (-)-Epicatechin 3-O-gallic acid | Generator | | (-)-Epicatechin gallate | HMDB | | (-)-Epicatechin-3-gallate | HMDB | | (-)-Epicatechin-3-O-gallate | HMDB | | Epicatechin gallate | HMDB, MeSH | | Epicatechin gallate, (2R-cis)-isomer | HMDB, MeSH | | Epicatechol, gallate | HMDB | | L-Epicatechin gallate | HMDB | | Epicatechin-3-O-gallate | MeSH, HMDB | | Epicatechin-3-gallate | MeSH, HMDB | | Epicatechin-3-galloyl ester | MeSH, HMDB | | Epicatechin 3-gallic acid | Generator | | (-)-Epicatechin 3-gallate | manual | | (-)-Epicatechin 3-O-gallate | manual | | Epicatechin 3-gallate | manual | | Epicatechol, 3-gallate, (-)- | biospider |
|
|---|
| Predicted Properties | |
|---|
| Chemical Formula | C22H18O10 |
|---|
| IUPAC name | (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate |
|---|
| InChI Identifier | InChI=1S/C22H18O10/c23-11-6-14(25)12-8-19(32-22(30)10-4-16(27)20(29)17(28)5-10)21(31-18(12)7-11)9-1-2-13(24)15(26)3-9/h1-7,19,21,23-29H,8H2/t19-,21-/m1/s1 |
|---|
| InChI Key | LSHVYAFMTMFKBA-TZIWHRDSSA-N |
|---|
| Isomeric SMILES | OC1=CC(O)=C2C[C@@H](OC(=O)C3=CC(O)=C(O)C(O)=C3)[C@H](OC2=C1)C1=CC=C(O)C(O)=C1 |
|---|
| Average Molecular Weight | 442.376 |
|---|
| Monoisotopic Molecular Weight | 442.08999678 |
|---|
| Classification |
|---|
| Description | Belongs to the class of organic compounds known as catechin gallates. These are organic compounds containing a gallate moiety glycosidically linked to a catechin. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Phenylpropanoids and polyketides |
|---|
| Class | Flavonoids |
|---|
| Sub Class | Flavans |
|---|
| Direct Parent | Catechin gallates |
|---|
| Alternative Parents | |
|---|
| Substituents | - Catechin gallate
- 3'-hydroxyflavonoid
- 4'-hydroxyflavonoid
- 5-hydroxyflavonoid
- 7-hydroxyflavonoid
- Hydroxyflavonoid
- Galloyl ester
- Gallic acid or derivatives
- P-hydroxybenzoic acid alkyl ester
- M-hydroxybenzoic acid ester
- P-hydroxybenzoic acid ester
- Benzoate ester
- Chromane
- Benzopyran
- 1-benzopyran
- Benzenetriol
- Benzoic acid or derivatives
- Pyrogallol derivative
- Catechol
- Benzoyl
- Phenol
- Alkyl aryl ether
- 1-hydroxy-4-unsubstituted benzenoid
- 1-hydroxy-2-unsubstituted benzenoid
- Benzenoid
- Monocyclic benzene moiety
- Carboxylic acid ester
- Carboxylic acid derivative
- Monocarboxylic acid or derivatives
- Ether
- Oxacycle
- Organoheterocyclic compound
- Polyol
- Organooxygen compound
- Organic oxygen compound
- Hydrocarbon derivative
- Organic oxide
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
|
| Disposition | Route of exposure: Source: Biological location: |
|---|
| Role | Biological role: |
|---|
| Physico-Chemical Properties |
|---|
| Physico-Chemical Properties - Experimental | | Property | Value | Reference |
|---|
| Physical state | Not Available | |
|---|
| Physical Description | Not Available | |
|---|
| Mass Composition | C 59.73%; H 4.10%; O 36.17% | DFC |
|---|
| Melting Point | Mp 257-258° (253°) | DFC |
|---|
| Boiling Point | Not Available | |
|---|
| Experimental Water Solubility | Not Available | |
|---|
| Experimental logP | Not Available | |
|---|
| Experimental pKa | Not Available | |
|---|
| Isoelectric point | Not Available | |
|---|
| Charge | Not Available | |
|---|
| Optical Rotation | [a]23D -160.6 (c, 0.22 in Me2CO) | DFC |
|---|
| Spectroscopic UV Data | Not Available | |
|---|
| Density | Not Available | |
|---|
| Refractive Index | Not Available | |
|---|
|
|---|
| Spectra |
|---|
| Spectra | |
|---|
| EI-MS/GC-MS | | Type | Description | Splash Key | View |
|---|
| Predicted GC-MS | Epicatechin 3-gallate, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | splash10-0umi-0920000000-718b2102383cc9dc533e | Spectrum | | Predicted GC-MS | Epicatechin 3-gallate, 3 TMS, Predicted GC-MS Spectrum - 70eV, Positive | splash10-004l-1490224000-de77e2646c7aba3a8def | Spectrum | | Predicted GC-MS | Epicatechin 3-gallate, TBDMS_3_23, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Epicatechin 3-gallate, TBDMS_4_19, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Epicatechin 3-gallate, TBDMS_4_25, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Epicatechin 3-gallate, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Epicatechin 3-gallate, "(-)-Epicatechin 3-O-gallate,3TBDMS,#23" TMS, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum |
|
|---|
| MS/MS | | Type | Description | Splash Key | View |
|---|
| MS/MS | LC-MS/MS Spectrum - Linear Ion Trap , negative | splash10-000i-0292000000-ece704ccdb047a088d28 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Linear Ion Trap , negative | splash10-000i-0292000000-d89b96c676e7c3398d8f | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - , negative | splash10-0170-0950000000-685c095616785cc82303 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - , negative | splash10-014i-0940200000-84b58b678cc59833a025 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Linear Ion Trap , positive | splash10-00di-0290000000-440ff7c7a589e1c058b5 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Linear Ion Trap , positive | splash10-00di-0290000000-8f606522637d9033c95f | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Linear Ion Trap , positive | splash10-0002-0098500000-0c0b2ca06b9e49aa356b | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Linear Ion Trap , positive | splash10-0002-0097500000-7a41879feecb968154e9 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Linear Ion Trap , positive | splash10-03di-0029600000-77ceea44aa3ce7f822f9 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Linear Ion Trap , positive | splash10-03di-0029600000-7f271696d73430ee7463 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - , positive | splash10-00di-0900000000-21da01e01ba7fa12d6cb | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 40V, Positive | splash10-00dr-0900000000-1b53eabb63f51dd0886f | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 35V, Negative | splash10-014i-0900000000-e435428b44afb21a7eee | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 20V, Positive | splash10-00dr-0900000000-a3b08dd3f89619c2d4f3 | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 10V, Positive | splash10-00di-0930000000-19d10b8c4fe8d2256c14 | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 10V, Negative | splash10-014u-0960500000-6417fae4919951138986 | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 20V, Negative | splash10-014i-0940000000-ce6989df78eb09b24d1f | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 40V, Negative | splash10-004i-0900000000-cff394f106b307da1857 | 2021-09-20 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-000l-0920400000-e7005e91544f51f7efe1 | 2016-08-03 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0079-0910000000-a428a4e56e1884d5b86a | 2016-08-03 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0079-2900000000-d86fe441a677946b2205 | 2016-08-03 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0006-0310900000-98e9c41598a749627127 | 2016-08-03 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0gdl-0913300000-af1ea1d6588fca8f1f9f | 2016-08-03 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-00or-0900000000-60192713dbf412058de2 | 2016-08-03 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0006-0130900000-406473c14c03e2f28625 | 2021-09-22 | View Spectrum |
|
|---|
| NMR | Not Available |
|---|
| External Links |
|---|
| ChemSpider ID | 97034 |
|---|
| ChEMBL ID | CHEMBL36327 |
|---|
| KEGG Compound ID | Not Available |
|---|
| Pubchem Compound ID | 107905 |
|---|
| Pubchem Substance ID | Not Available |
|---|
| ChEBI ID | Not Available |
|---|
| Phenol-Explorer ID | 128 |
|---|
| DrugBank ID | Not Available |
|---|
| HMDB ID | HMDB37944 |
|---|
| CRC / DFC (Dictionary of Food Compounds) ID | CML31-M:KWF59-Y |
|---|
| EAFUS ID | Not Available |
|---|
| Dr. Duke ID | EPICATECHIN-GALLATE|(-)-EPICATECHIN-GALLATE|(-)-EPICATECHOL-GALLATE|1-EPICATECHIN-GALLATE|EPICATECHIN-3-O-GALLATE|EPICATECHOL-GALLATE|(-)-EPICATECHIN-3-O-GALLATE|(-)-EPICATECHIN-3-GALLATE|EPICATECHIN-3-GALLATE |
|---|
| BIGG ID | Not Available |
|---|
| KNApSAcK ID | C00008866 |
|---|
| HET ID | Not Available |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| Flavornet ID | Not Available |
|---|
| GoodScent ID | Not Available |
|---|
| SuperScent ID | Not Available |
|---|
| Wikipedia ID | Not Available |
|---|
| Phenol-Explorer Metabolite ID | 128 |
|---|
| Duplicate IDS | Not Available |
|---|
| Old DFC IDS | Not Available |
|---|
| Associated Foods |
|---|
| Food | Content Range | Average | Reference |
|---|
| Food | | | Reference |
|---|
|
| Biological Effects and Interactions |
|---|
| Health Effects / Bioactivities | | Descriptor | ID | Definition | Reference |
|---|
| Angiotensin converting enzyme inhibitor | 35457 | An agent that blocks the conversion of angiotensin I to angiotensin II, reducing blood pressure and fluid retention. Therapeutically, it's used to treat hypertension, heart failure, and protect kidney function in diabetes, thereby reducing the risk of cardiovascular disease and stroke. | DUKE | | Acetyl-CoA-carboxylase inhibitor | 23924 | An agent that blocks the activity of acetyl-CoA-carboxylase, a key enzyme in fatty acid synthesis, reducing lipid production. Therapeutically, it is used to manage obesity, hyperlipidemia, and type 2 diabetes by decreasing fat storage and improving insulin sensitivity. | DUKE | | Anti cariogenic | 52217 | An agent that prevents tooth decay, reducing bacterial acid production and plaque formation. Its biological role is to inhibit the growth of cariogenic bacteria, and its therapeutic applications include preventing dental caries and managing tooth decay. Key medical uses include toothpaste, mouthwashes, and dental varnishes to maintain oral health. | DUKE | | Anti hepatotoxic | 62868 | An agent that protects the liver from damage, reducing toxicity and promoting liver health. It plays a biological role in preventing liver injury and supporting liver function. Therapeutically, it is used to treat liver diseases, such as hepatitis and cirrhosis, and to counteract liver-damaging effects of certain medications and toxins. | DUKE | | Anti HIV | 22587 | An agent that prevents the replication of the Human Immunodeficiency Virus (HIV), used to treat and manage HIV infection and Acquired Immunodeficiency Syndrome (AIDS), reducing viral load and slowing disease progression. | DUKE | | Anti-mutagenic | | An agent that interferes with the mutagenicity of a substance, preventing DNA damage and mutations. Its biological role is to protect cells from genetic alterations, and it has therapeutic applications in cancer prevention and treatment, as well as key medical uses in reducing the risk of genetic disorders and birth defects. | DUKE | | Anti-oxidant | 22586 | An agent that neutralizes free radicals, reducing oxidative stress and cell damage. Its biological role involves protecting cells from harm, and it has therapeutic applications in managing chronic diseases, such as cancer, diabetes, and neurodegenerative disorders, with key medical uses including anti-aging, anti-inflammatory, and cardio protective effects. | DUKE | | Anti peroxidant | | An agent that prevents oxygen atom and peroxide formation, reducing oxidative stress and cell damage. It plays a biological role in protecting cells from free radicals. Therapeutically, it's used to manage conditions like cancer, Alzheimer's, and atherosclerosis, with key medical applications in neuroprotection, cardiovascular health, and anti-aging. | DUKE | | Anti-viral | 22587 | An agent that inhibits the replication of viruses, playing a crucial role in preventing and treating viral infections. Therapeutically, anti-virals are used to manage diseases such as HIV, herpes, and influenza, reducing symptoms and slowing disease progression. Key medical uses include treating viral hepatitis, respiratory syncytial virus, and COVID-19. | DUKE | | Cancer preventive | 35610 | An agent that inhibits the development and progression of cancer, reducing tumor formation and growth. It plays a biological role in blocking carcinogenic pathways, and has therapeutic applications in chemoprevention. Key medical uses include reducing the risk of cancer in high-risk individuals and preventing cancer recurrence. | DUKE | | Catechol O-methyltransferase inhibitor | 48406 | An agent that blocks the activity of catechol O-methyltransferase, an enzyme involved in breaking down catecholamines. Therapeutically, it increases dopamine levels, commonly used in managing Parkinson's disease, depression, and anxiety disorders, as well as treating pain and fibromyalgia. | DUKE | | Cytotoxic | 52209 | An agent that kills or damages cells, playing a biological role in immune responses and therapeutic applications in cancer treatment. Key medical uses include chemotherapy, targeting and destroying cancer cells, and treating certain autoimmune diseases by eliminating harmful cells. | DUKE | | Glucosyl-transferase inhibitor | 23924 | An agent that blocks the activity of glucosyl-transferase enzymes, preventing glycoprotein and glycolipid synthesis. It has therapeutic applications in cancer, infectious diseases, and inflammatory disorders, with key medical uses including anti-tumor, anti-viral, and anti-inflammatory treatments. | DUKE | | Immunostimulant | 50847 | An agent that stimulates the immune system, enhancing its response to infections and diseases. Therapeutically, it boosts the body's natural defenses, commonly used to treat immunodeficiency disorders, prevent infections, and support cancer treatment, as well as manage chronic conditions like hepatitis and HIV. | DUKE | | Lipoxygenase inhibitor | 35856 | An agent that blocks the activity of lipoxygenase enzymes, reducing inflammation and oxidative stress. Therapeutically, it's used to manage conditions like asthma, atherosclerosis, and cancer, by inhibiting the production of pro-inflammatory leukotrienes. Key medical uses include treating respiratory and cardiovascular diseases. | DUKE | | Methyl-guanidine inhibitor | 35222 | An agent that blocks the activity of inducible nitric oxide synthase (iNOS), reducing nitric oxide production. Therapeutically, it has anti-inflammatory and neuroprotective effects, commonly used in managing conditions such as arthritis, sepsis, and neurodegenerative diseases. | DUKE | | Mitogen | 52290 | A substance that induces cell division and proliferation, playing a key role in growth and development. Therapeutically, mitogens are used to stimulate tissue repair and regeneration. Medical applications include wound healing, tissue engineering, and cancer treatment, where mitogens can enhance chemotherapy efficacy or support hematopoiesis. | DUKE | | Nephroprotective | 76595 | An agent that protects the kidneys from damage, reducing inflammation and oxidative stress. Therapeutically, it helps prevent or treat kidney diseases, such as nephropathy and acute kidney injury, and is used in managing conditions like diabetes and hypertension to preserve renal function. | DUKE | | Xanthine oxidase inhibitor | 35634 | An agent that blocks xanthine oxidase, an enzyme involved in uric acid production, reducing inflammation and oxidative stress. Therapeutically, it's used to treat gout, hyperuricemia, and prevent kidney stones, with key applications in managing cardiovascular disease and improving kidney function. | DUKE | | Alpha-amylase inhibitor | 50627 | An agent that blocks the activity of alpha-amylase, an enzyme that breaks down carbohydrates. It reduces carbohydrate digestion and absorption, commonly used in managing diabetes, obesity, and weight loss, with potential therapeutic applications in glycemic control and metabolic disorders. | CHEBI |
|
|---|
| Enzymes | Not Available |
|---|
| Pathways | Not Available |
|---|
| Metabolism | Not Available |
|---|
| Biosynthesis | Not Available |
|---|
| Organoleptic Properties |
|---|
| Flavours | | Flavor | Citations |
|---|
| bitter |
- Ayana Wiener, Marina Shudler, Anat Levit, Masha Y. Niv. BitterDB: a database of bitter compounds. Nucleic Acids Res 2012, 40(Database issue):D413-419. DOI:10.1093/nar/gkr755
|
|
|---|
| Files |
|---|
| MSDS | Not Available |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| General Reference | Not Available |
|---|
| Content Reference | — Rothwell JA, Pérez-Jiménez J, Neveu V, Medina-Ramon A, M'Hiri N, Garcia Lobato P, Manach C, Knox K, Eisner R, Wishart D, Scalbert A. (2013) Phenol-Explorer 3.0: a major update of the Phenol-Explorer database to incorporate data on the effects of food processing on polyphenol content. Database, 10.1093/database/bat070. — Shinbo, Y., et al. 'KNApSAcK: a comprehensive species-metabolite relationship database.' Plant Metabolomics. Springer Berlin Heidelberg, 2006. 165-181. — Duke, James. 'Dr. Duke's Phytochemical and Ethnobotanical Databases. United States Department of Agriculture.' Agricultural Research Service, Accessed April 27 (2004).
|
|---|